AlzChem Group AG (ACT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AlzChem Group AG (ACT) has a cash flow conversion efficiency ratio of 0.136x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€37.67 Million ≈ $44.04 Million USD) by net assets (€276.06 Million ≈ $322.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AlzChem Group AG balance sheet quality to measure how much of total assets are equity-financed.
AlzChem Group AG - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how AlzChem Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ACT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
AlzChem Group AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AlzChem Group AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FirstSun Capital Bancorp Common Stock
NASDAQ:FSUN
|
-0.011x |
|
Vericel Corp Ord
NASDAQ:VCEL
|
0.042x |
|
Believe SAS
PA:BLV
|
0.049x |
|
Acuren Corporation
NYSE:TIC
|
0.005x |
|
Modern Times Group Mtg AB
ST:MTG-B
|
0.079x |
|
Wangfujing
SHG:600859
|
0.036x |
|
Sinosoft Co Ltd
SHG:603927
|
-0.043x |
|
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238
|
0.027x |
Annual Cash Flow Conversion Efficiency for AlzChem Group AG (2012–2025)
The table below shows the annual cash flow conversion efficiency of AlzChem Group AG from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see AlzChem Group AG market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €258.23 Million ≈ $301.90 Million |
€137.01 Million ≈ $160.18 Million |
0.531x | +4.69% |
| 2024-12-31 | €207.47 Million ≈ $242.56 Million |
€105.15 Million ≈ $122.93 Million |
0.507x | +14.07% |
| 2023-12-31 | €163.56 Million ≈ $191.22 Million |
€72.67 Million ≈ $84.96 Million |
0.444x | +1629.37% |
| 2022-12-31 | €145.95 Million ≈ $170.63 Million |
€-4.24 Million ≈ $-4.96 Million |
-0.029x | -106.05% |
| 2021-12-31 | €89.56 Million ≈ $104.71 Million |
€43.02 Million ≈ $50.29 Million |
0.480x | -32.30% |
| 2020-12-31 | €68.66 Million ≈ $80.27 Million |
€48.71 Million ≈ $56.95 Million |
0.709x | -0.24% |
| 2019-12-31 | €61.35 Million ≈ $71.72 Million |
€43.63 Million ≈ $51.01 Million |
0.711x | +40.35% |
| 2018-12-31 | €68.39 Million ≈ $79.96 Million |
€34.66 Million ≈ $40.52 Million |
0.507x | -4.33% |
| 2017-12-31 | €57.89 Million ≈ $67.68 Million |
€30.66 Million ≈ $35.85 Million |
0.530x | -- |
| 2016-12-31 | €0.00 ≈ $0.00 |
€-36.08K ≈ $-42.18K |
x | -- |
| 2015-12-31 | €0.00 ≈ $0.00 |
€-49.19K ≈ $-57.50K |
x | -- |
| 2014-12-31 | €0.00 ≈ $0.00 |
€140.11 ≈ $163.80 |
x | -- |
| 2013-12-31 | €1.94K ≈ $2.27K |
€15.57 Million ≈ $18.21 Million |
8036.636x | +243.97% |
| 2012-12-31 | €8.86K ≈ $10.36K |
€20.71 Million ≈ $24.21 Million |
2336.416x | -- |
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, f… Read more